Machado Andrade Viviane, Stevenson Mario
Molecular Cell and Developmental Biology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.
Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.
J Neuroimmune Pharmacol. 2019 Mar;14(1):33-43. doi: 10.1007/s11481-018-9795-4. Epub 2018 Jul 11.
HIV-1 persists in cellular reservoirs that cannot be eliminated by antiretroviral therapy (ART). The major reservoir in infected individuals on effective ART is composed of resting memory CD4+ T cells that harbor proviral cDNA, and undergo a state of latency in which viral gene expression is minimal to absent. The CD4+ T cell reservoir has been extensively characterized. However, other HIV-1-permissive cells may contribute to HIV-1 persistence. Lentiviruses have a long recognized association with macrophages. However, the role, if any, played by macrophages in HIV-1 persistence is not well understood. Macrophages are resistant to cell death upon HIV-1 infection, and can survive for long periods of time, making them ideal host cells in which the virus might persist. Studying macrophages is challenging, as these cells reside in nearly all tissues. Moreover, detecting viral DNA or RNA in macrophages does not necessarily indicate that these cells will produce replication-competent viral particles. Currently, the gold standard assay to detect cellular reservoirs is the ex vivo quantitative viral outgrowth assay (QVOA), which requires a patient blood draw. However, macrophages reside deep within tissues that are inaccessible in living subjects, such as the central nervous system (CNS). Therefore, tools other than QVOA must be developed to identify cellular reservoirs that reside in the tissues. In this review, we will focus on the main aspects involved in HIV-1 persistence, including the molecular mechanisms of viral evasion, the main cell types responsible for harboring persistent HIV-1 and the tissue compartments that are likely to be reservoirs for HIV-1.
人类免疫缺陷病毒1型(HIV-1)持续存在于抗逆转录病毒疗法(ART)无法清除的细胞储存库中。接受有效ART治疗的感染者体内的主要储存库由携带前病毒cDNA的静止记忆CD4+T细胞组成,这些细胞处于潜伏状态,病毒基因表达极少或不存在。CD4+T细胞储存库已得到广泛表征。然而,其他允许HIV-1感染的细胞可能也有助于HIV-1的持续存在。慢病毒与巨噬细胞之间的关联早已为人所知。然而,巨噬细胞在HIV-1持续存在中所起的作用(如果有)尚未得到充分了解。巨噬细胞在感染HIV-1后对细胞死亡具有抗性,并且可以存活很长时间,这使其成为病毒可能持续存在的理想宿主细胞。研究巨噬细胞具有挑战性,因为这些细胞几乎存在于所有组织中。此外,在巨噬细胞中检测病毒DNA或RNA并不一定表明这些细胞会产生具有复制能力的病毒颗粒。目前,检测细胞储存库的金标准检测方法是体外定量病毒生长检测法(QVOA),该方法需要采集患者血液。然而,巨噬细胞存在于活体受试者难以触及的组织深处,如中枢神经系统(CNS)。因此,必须开发除QVOA之外的工具来识别存在于组织中的细胞储存库。在这篇综述中,我们将重点关注HIV-1持续存在所涉及的主要方面,包括病毒逃逸的分子机制、负责储存持续性HIV-1的主要细胞类型以及可能成为HIV-1储存库的组织区室。